S1 filings / 51
#51
| id | 51 |
|---|---|
| company_id | 8489 |
| ticker | EMI |
| filing_date | 2026-07-01 |
| filing_url | https://www.sec.gov/Archives/edgar/data/0001838003/000110465926079489/ |
| business_description | Encore Medical develops, manufactures, and markets septal occlusion devices—small, implantable devices delivered through a catheter to pe... |
| total_revenue | $2.586M (FY2025) |
| operating_loss | -$829,149 (FY2025) |
| cash_burn | — |
| total_assets | $2.160M (FY2025) |
| created_at | 2026-07-11T21:14:18.902096+00:00 |
| updated_at | 2026-07-22T09:17:57.7134+00:00 |
| total_revenue_usd | 2585858 |
| operating_loss_usd | -829149 |
| cash_burn_usd | — |
| total_assets_usd | 2160381 |
| source_record_id | 1258 |
| tenant_id | 1 |